These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3418392)

  • 1. Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms.
    Cho KG; Nagashima T; Barnwell S; Hoshino T
    J Neurosurg; 1988 Oct; 69(4):588-92. PubMed ID: 3418392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
    J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.
    Nishizaki T; Orita T; Furutani Y; Ikeyama Y; Aoki H; Sasaki K
    J Neurosurg; 1989 Mar; 70(3):379-84. PubMed ID: 2536805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
    Hoshino T; Prados M; Wilson CB; Cho KG; Lee KS; Davis RL
    J Neurosurg; 1989 Sep; 71(3):335-41. PubMed ID: 2549222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of DNA index in human brain tumors.
    Nishizaki T; Ohshita N; Nagatsugu Y; Orita T; Ito H; Sasaki K
    J Neurooncol; 1993 Jul; 17(1):9-13. PubMed ID: 8120576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine.
    Hoshino T; Nagashima T; Cho KG; Murovic JA; Hodes JE; Wilson CB; Edwards MS; Pitts LH
    Int J Cancer; 1986 Sep; 38(3):369-74. PubMed ID: 3527993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T; Hoshino T
    No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of the proliferative potential of low-grade astrocytomas.
    Hoshino T; Rodriguez LA; Cho KG; Lee KS; Wilson CB; Edwards MS; Levin VA; Davis RL
    J Neurosurg; 1988 Dec; 69(6):839-42. PubMed ID: 3193189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
    Nagashima T; Hoshino T
    No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
    Danova M; Riccardi A; Gaetani P; Wilson GD; Mazzini G; Brugnatelli S; Buttini R; Butti G; Ucci G; Paoletti P
    Eur J Cancer Clin Oncol; 1988 May; 24(5):873-80. PubMed ID: 3169092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in the proliferative potential of human gliomas.
    Hoshino T; Nagashima T; Cho KG; Davis RL; Donegan J; Slusarz M; Wilson CB
    J Neurooncol; 1989 Jul; 7(2):137-43. PubMed ID: 2550593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors.
    Nagashima T; Hoshino T; Cho KG; Senegor M; Waldman F; Nomura K
    J Neurosurg; 1988 Mar; 68(3):388-92. PubMed ID: 3278075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
    Hoshino T; Ahn D; Prados MD; Lamborn K; Wilson CB
    Int J Cancer; 1993 Feb; 53(4):550-5. PubMed ID: 8382191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
    Miyakawa A; Tachibana M; Tazaki H
    Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.
    Murovic JA; Nagashima T; Hoshino T; Edwards MS; Davis RL
    Neurosurgery; 1986 Dec; 19(6):900-4. PubMed ID: 3027608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of histopathological features and proliferative potential of gliomas.
    Germano IM; Ito M; Cho KG; Hoshino T; Davis RL; Wilson CB
    J Neurosurg; 1989 May; 70(5):701-6. PubMed ID: 2709110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
    Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
    Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres.
    McDermott MW; Krouwer HG; Asai A; Ito S; Hoshino T; Prados MD
    Can J Neurol Sci; 1992 Feb; 19(1):34-9. PubMed ID: 1562905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell kinetics of glial tumors.
    Hoshino T
    Rev Neurol (Paris); 1992; 148(6-7):396-401. PubMed ID: 1448658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.